Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Genital Candida Species Detected in Samples from Women in Melbourne, Australia, before and after Treatment with Antibiotics
2006
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
1999
The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo
1992
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
1994
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Testicular Germ-Cell Cancer
1997 Standout
Vulvovaginal candidosis
2007 Standout
rhGGF2 protects against cisplatin-induced neuropathy in the rat
2000
Cancer to bone: a fatal attraction
2011 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis
1992
Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer
1990
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
5,7-Dihydroxychromone-2-carboxylic acid and it's transition-metal (Mn and Zn) chelates as non-thiol radioprotective agents
2007
Paclitaxel (Taxol)
1995 Standout
Amifostine in clinical oncology: current use and future applications
2002
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
2000
Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.
1996
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.
1998
A prospective surveillance model for physical rehabilitation of women with breast cancer
2012
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Carnitine Deficiency Provokes Cisplatin‐Induced Hepatotoxicity in Rats
2007
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Block copolymer micelles for drug delivery: design, characterization and biological significance
2001 Standout
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
1994
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Study of ORG 2766 in the Prevention or Delay of Cisplatin-Induced Neuropathies in Women with Ovarian Cancer
1997
Toxicity of platinum compounds
2003
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody
1999
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors
2000
The pathobiology of mucositis
2004 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
1991
Identification of yeasts in public hospital primary care patients with or without clinical vaginitis
2003
Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
1992
Relationship of Fungal Vaginitis Therapy to Prior Antibiotic Exposure
2003
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer
2001
Management of Metastatic Melanoma 2005
2006
Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies
1994
Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin
1997
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients
2003
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
Pharmacokinetics of amifostine and its metabolites in patients
1997
Radioprotective Effects of 2-Imino-3-[(chromone-2-yl)carbonyl] thiazolidines against γ-Irradiation in Mice
2002
Toxicity antagonists in head and neck cancer
1998
The potential role of bisphosphonates in prostate cancer
2002
Doxorubicin-Induced Cardiomyopathy
1998 Standout
WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
1993
Head and Neck Cancer
2001 Standout
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases
2000
Cancer of the Ovary
2004 Standout
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
1994
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Tumour stem cells and drug resistance
2005 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Interventions for preventing neuropathy caused by cisplatin and related compounds
2014
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
2002 Standout
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
2003
Pamidronate Reduces Skeletal Morbidity in Women With Advanced Breast Cancer and Lytic Bone Lesions: A Randomized, Placebo-Controlled Trial
1999
Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid
2005
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood
2016
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
2002
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
The Influence of Hypermagnesemia on Serum Calcium and Parathyroid Hormone Levels in Human Subjects
1984
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
2002
Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?
1999
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma
2004
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Platinum resistance: Laboratory findings and clinical implications
1993
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
2007
Cannabinoids for Medical Use
2015 Standout
The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester
2005
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
γδ T cells for immune therapy of patients with lymphoid malignancies
2003
New Therapies for Ovarian Cancer
1992
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Metabolic emergencies in clinical oncology.
1989
A systematic review of the role of bisphosphonates in metastatic disease
2004
The current status of new platinum analogs.
1992
Works of Donna Glover being referenced
Phase I/II trials of WR-2721 and cis-platinum
1986
Clinical trials of WR-2721 and cis-platinum
1989
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma
1988
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma
2001
Pharmacokinetics of WR-2721
1988
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study
1994
Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma
2003
A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer
1988
Metabolic Oncologic Emergencies
1987
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
1988
Longitudinal Investigation of Candida Vaginitis in Pregnancy: Role of Superimposed Antibiotic Use
1998
Alterations in oxygen transport following WR-2721
1984
Phase I Controlled trials of WR-2721 and cyclophosphamide
1984
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.
1987
Toxicity of WR-2721 administered in single and multiple doses
1984
WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial.
1986
Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer.
1994
Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)
1983
Human pharmacokinetics of WR-2721
1986
Clinical trials of WR-2721 with radiation therapy
1982
Phase I trials of WR-2721 and cis-platinum
1984
High-dose oral metoclopramide
1985
Unusual presentation of cis‐platinum Neuropathy
1988
A Liquid Chromatographic Electrochemical Assay for S-2-(3-Aminopropylamino) Ethylphosphorothioate (WR2721) in Human Plasma
1984